Takao Hoshino Selected Research

Tissue Plasminogen Activator (Alteplase)

1/2017

Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation .

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takao Hoshino Research Topics

Disease

10	Stroke (Strokes) 04/2024 - 01/2017
4	Pathologic Constriction (Stenosis) 07/2022 - 11/2014
3	Ischemic Stroke 11/2022 - 03/2019
2	Acute Coronary Syndrome 01/2023 - 11/2022
2	Atherosclerosis 11/2022 - 07/2022
2	Infarction (Infarctions) 11/2022 - 01/2017
2	Dyslipidemias (Dyslipidemia) 07/2022 - 01/2017
2	Hypertriglyceridemia 07/2022 - 01/2022
2	Infections 03/2022 - 10/2018
1	Insulin Resistance 11/2022
1	Transient Ischemic Attack 11/2022
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2022
1	Cerebral Arterial Diseases 07/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2022
1	Chronic Hepatitis (Chronic Active Hepatitis) 03/2022
1	Embolic Stroke 03/2019
1	Hemiplegia (Spastic Hemiplegia) 02/2019
1	Hepatitis C 10/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Diabetes Mellitus 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Peripheral Arterial Disease 01/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017
1	Hypothermia 05/2015
1	Ischemia 05/2015
1	Hypoxia (Hypoxemia) 05/2015
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 05/2015
1	Human Influenza (Influenza) 01/2012

Drug/Important Bio-Agent (IBA)

4	omega-Chloroacetophenone (Mace)IBA 01/2023 - 01/2018
3	Triglycerides (Triacylglycerol)IBA 11/2022 - 01/2022
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2017 - 11/2014
1	LipidsIBA 04/2024
1	HomocysteineIBA 09/2023
1	Glucose (Dextrose)FDA LinkGeneric 11/2022
1	salicylhydroxamic acid (SHAM)IBA 11/2022
1	N(G)-iminoethylornithineIBA 11/2022
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 11/2022
1	MK 2206IBA 11/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2022
1	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 07/2022
1	PPAR alphaIBA 07/2022
1	EnzymesIBA 07/2022
1	glecaprevir and pibrentasvirIBA 03/2022
1	LDL CholesterolIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2019
1	terutrobanIBA 03/2019
1	SteroidsIBA 02/2019
1	Acyclovir (Aciclovir)FDA LinkGeneric 02/2019
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 02/2019
1	paritaprevirIBA 10/2018
1	Ritonavir (Norvir)FDA Link 10/2018
1	ombitasvirIBA 10/2018
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2017
1	AnticoagulantsIBA 01/2017
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2017
1	Neuroprotective AgentsIBA 05/2015
1	Choline (Choline Chloride)IBA 05/2015
1	Carnitine (L-Carnitine)FDA LinkGeneric 05/2015
1	CarbonIBA 05/2015
1	Pyruvic Acid (Pyruvate)IBA 05/2015
1	Amino Acids FDA Link 05/2015
1	Acetylcholine (Acetylcholine Chloride)FDA Link 05/2015
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 05/2015
1	AntibodiesIBA 01/2012
1	GangliosidesIBA 01/2012

Therapy/Procedure

3	Therapeutics 07/2022 - 02/2019
2	Secondary Prevention 02/2024 - 03/2019
1	Renal Dialysis (Hemodialysis) 09/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 09/2022
1	Stents 06/2022
1	Aftercare (After-Treatment) 03/2022
1	Induced Hypothermia 05/2015